We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,162 results
  1. Natural Language Processing for Drug Discovery Knowledge Graphs: Promises and Pitfalls

    Building and analyzing knowledge graphs (KGs) to aid drug discovery is a topical area of research. A salient feature of KGs is their ability to...
    J. Charles G. Jeynes, Tim James, Matthew Corney in High Performance Computing for Drug Discovery and Biomedicine
    Protocol 2024
  2. Cellular Blood Flow Modeling with HemoCell

    Many of the intriguing properties of blood originate from its cellular nature. Bulk effects, such as viscosity, depend on the local shear rates and...
    Gabor Zavodszky, Christian Spieker, ... Britt van Rooij in High Performance Computing for Drug Discovery and Biomedicine
    Protocol 2024
  3. A Blood Flow Modeling Framework for Stroke Treatments

    Circulatory models can significantly help develop new ways to alleviate the burden of stroke on society. However, it is not always easy to know what...
    Remy Petkantchin, Franck Raynaud, ... Bastien Chopard in High Performance Computing for Drug Discovery and Biomedicine
    Protocol 2024
  4. Teaching Medical Students to Use Supercomputers: A Personal Reflection

    At the “Kick Off” meeting for CompBioMed (compbiomed.eu), which was first funded in October 2016, I had no idea that one single sentence (“I wish I...
    Protocol 2024
  5. Automated Virtual Screening

    Computational methods in modern drug discovery have become ubiquitous, with methods that cover most of the discovery stages: from hit finding and...
    Protocol 2024
  6. Alzheimer’s Disease Prevention and Treatment Based on Population-Based Approaches

    The development of effective prevention and treatment strategies for Alzheimer’s disease (AD) and dementia is hindered by limited knowledge of the...
    Protocol 2024
  7. CSF N-Glycomics Using MALDI MS Techniques

    In this chapter, we will present the methodology currently applied in our laboratory for the structural elucidation of the cerebrospinal fluid (CSF)...
    Angela Messina, Donata Agata Romeo, ... Domenico Garozzo in Biomarkers for Alzheimer’s Disease Drug Development
    Protocol 2024
  8. CSF N-Glycomics Using High-Throughput UPLC-ESI Techniques in Alzheimer’s Disease

    In this chapter, we will present a high-throughput method applied in our laboratory for the structural elucidation of the cerebrospinal fluid (CSF)...
    Angela Messina, Rita Barone, ... Domenico Garozzo in Biomarkers for Alzheimer’s Disease Drug Development
    Protocol 2024
  9. In Silico Models to Validate Novel Blood-Based Biomarkers

    Biological validation of preliminary findings is a key prerequisite in biomarker discovery. In recent years, the development of advanced large-scale...
    Protocol 2024
  10. Mass Spectrometry-Based Metabolomics Multi-platform for Alzheimer’s Disease Research

    The integration of complementary analytical platforms is nowadays the most common strategy for comprehensive metabolomics analysis of complex...
    Álvaro González-Domínguez, Ana Sayago, ... Raúl González-Domínguez in Biomarkers for Alzheimer’s Disease Drug Development
    Protocol 2024
  11. High-Throughput Lipidomic and Metabolomic Profiling for Brain Tissue and Biofluid Samples in Neurodegenerative Disorders

    Recent research has revealed the potential of lipidomics and metabolomics in identifying new biomarkers and mechanistic insights for...
    Bonne M. Thompson, Giuseppe Astarita in Biomarkers for Alzheimer’s Disease Drug Development
    Protocol 2024
  12. Magnetic Resonance Spectroscopy (MRS) in Alzheimer’s Disease

    MRS is a noninvasive technique to measure different metabolites in the brain. Changes in the levels of certain metabolites can be used as surrogate...
    Nasim Sheikh-Bahaei, Michelle Chen, Ioannis Pappas in Biomarkers for Alzheimer’s Disease Drug Development
    Protocol 2024
  13. Analysis of Resting-State Functional Magnetic Resonance Imaging in Alzheimer’s Disease

    Alzheimer’s disease (AD) has been characterized by widespread network disconnection among brain regions, widely overlap** with the hallmarks of the...
    Ersin Ersözlü, Boris-Stephan Rauchmann in Biomarkers for Alzheimer’s Disease Drug Development
    Protocol 2024
  14. Measuring Size and Number Concentration of Metallic Nanoparticles Using spICP-MS

    This protocol describes how to measure the size and concentration of individual metallic nanoparticles using inductively coupled plasma-mass...
    Matthew Hansen, Jeffrey D. Clogston in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  15. Methods for Analysis of Nanoparticle Immunosuppressive Properties

    Adverse drug effects on immune system function represent a significant concern in the pharmaceutical industry, because 10–20% of drug withdrawal from...
    Edward Cedrone, Timothy M. Potter, ... Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  16. Evaluation of the Acute Anaphylactoid Reactogenicity of Nanoparticle-Containing Medicines and Vaccines Using the Porcine CARPA Model

    A small fraction, up to 10%, of people treated intravenously with state-of-the-art nanoparticulate drugs or diagnostic agents develop an acute...
    Protocol 2024
  17. Immunophenoty**, Part I: Instrument Calibration and Reagent Qualification for Immunophenoty** Analysis of Human Peripheral Blood Mononuclear Cell Cultures

    Nanoparticles are increasingly used in biomedical applications to influence the way the immune system reacts to tumors and infectious disease-causing...
    Hannah S. Newton, Jenny Zhang, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  18. Ion Quantitation in Liposomal Products Using RP-HPLC with Charged Aerosol Detection

    Ion concentration in liposomal drugs is important for drug stability and drug release profile. However, quantifying ion concentration in liposomal...
    Protocol 2024
  19. Detection of Antigen Presentation by Murine Bone Marrow–Derived Dendritic Cells After Treatment with Nanoparticles

    Nanoparticles are frequently considered in vaccine applications due to their ability to co-deliver multiple antigens and adjuvants to...
    En** Hong, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  20. Detection of Pre-Existing Antibodies to Polyethylene Glycol and PEGylated Liposomes in Human Serum

    Polyethylene glycol, or PEG, is common in consumer products, over-the-counter medications, food, and pharmaceutical products. Concerns about PEG...
    Barry W. Neun, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
Did you find what you were looking for? Share feedback.